BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1634134)

  • 1. Flow-cytometric DNA analysis of stages IB and IIA cervical carcinoma.
    Zanetta GM; Katzmann JA; Keeney GL; Kinney WK; Cha SS; Podratz KC
    Gynecol Oncol; 1992 Jul; 46(1):13-9. PubMed ID: 1634134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The uses and limitations of DNA flow cytometry in stage IB or II cervical carcinoma.
    Lai CH; Hsueh S; Huang MY; Chang MF; Soong YK
    Cancer; 1993 Dec; 72(12):3655-62. PubMed ID: 8252482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Oct; 75(1):20-4. PubMed ID: 10502420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
    Kristensen GB; Kaern J; Abeler VM; Hagmar B; Tropé CG; Pettersen EO
    Gynecol Oncol; 1995 Apr; 57(1):79-85. PubMed ID: 7705705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric DNA analysis of early stage adenocarcinoma of the cervix.
    Magtibay PM; Perrone JF; Stanhope CR; Katzmann JA; Keeney GL; Li H
    Gynecol Oncol; 1999 Nov; 75(2):242-7. PubMed ID: 10525380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix.
    Kenter GG; Cornelisse CJ; Aartsen EJ; Mooy W; Hermans J; Heintz AP; Fleuren GJ
    Gynecol Oncol; 1990 Nov; 39(2):181-5. PubMed ID: 2227593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b.
    Horn LC; Raptis G; Nenning H
    Anal Quant Cytol Histol; 2002 Feb; 24(1):23-9. PubMed ID: 11865946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma.
    Wilailak S; Rochanawutanon M; Srisupundit S; Aumkhyan A; Pattanapanyasat K
    Eur J Gynaecol Oncol; 2004; 25(4):428-30. PubMed ID: 15285296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
    Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
    Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
    Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
    Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of tumor heterogeneity in cervical cancers and lymph node metastases as determined by flow cytometry.
    Nguyen HN; Sevin BU; Averette HE; Ramos R; Ganjei P; Perras J
    Cancer; 1993 Apr; 71(8):2543-50. PubMed ID: 8453577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer.
    Reich O; Pürstner P; Klaritsch P; Haas J; Lahousen M; Tamussino K; Winter R
    Eur J Gynaecol Oncol; 2003; 24(1):13-7. PubMed ID: 12691309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic flow cytometric information in cervical squamous cell carcinoma: a multivariate analysis of 307 patients.
    Strang P; Stendahl U; Bergström R; Frankendal B; Tribukait B
    Gynecol Oncol; 1991 Oct; 43(1):3-8. PubMed ID: 1959785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [DNA flow cytometry: perspective prognostic parameters in carcinoma of the uterine cervix].
    Anton M; Nenutil R; Kopecný J; Rejthar A; Zaloudík J; Hausner P; Ptácková B
    Cesk Gynekol; 1992 Apr; 57(2):49-55. PubMed ID: 1628337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear deoxyribonucleic acid ploidy in squamous cell bladder cancer.
    Winkler HZ; Nativ O; Hosaka Y; Farrow GM; Lieber MM
    J Urol; 1989 Feb; 141(2):297-302. PubMed ID: 2913348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ploidy level and short-time prognosis of early cervix cancer.
    Jakobsen A
    Radiother Oncol; 1984 Jan; 1(3):271-5. PubMed ID: 6505263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.